Is Epigenomics AG (EPGNF) a Buy, Sell, or Hold?
Epigenomics AG
OTC:EPGNF
$1.12 USD
$0 (0.0%)
- Volume
- 0
- Average Volume
- 555.89
- Market Capitalization
- $1M
- P/E Ratio
- -0.05
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $1.12
- Year Low
- $0.79
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.13
Industry, Sector & symbol
| Stock Exchange | OTC |
| CEO | Jason Wouhra |
| Industry | Medical - Specialties |
| Sector | Healthcare |
| Current Symbol | EPGNF |
| CUSIP | G3163R109 |
| CIK | None |
| Web | https://www.epigenomics.com |
| Phone | 49 30 243 450 |
| Currency | USD |
| Employees | 3 |
| Country | DE |
Liquidity
| Debt-to-Equity Ratio | 0.08 |
| Payout Ratio | 0.00 |
| Current Ratio | 2.13 |
| Quick Ratio | 2.12 |
| Cash Ratio | 1.98 |
Sales & Book Value
| Annual Sales | $23990 |
| Price / Sales | 1.26 |
| Cash Flow | -3.29 |
| Price / Cash Flow | -0.05 |
| Price / Book | 0.28 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | N/A |
| Rating Score(0-5) | 0 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.36 |
| Trailing P/E Ratio | -0.05 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | $-313.88K |
| Net Margin | -2479.18% |
| Pretax Margin | -2495.05% |
| Return on Equity | -74.47% |
| Return on Assets | -75.85% |
Financials Score
| AltmanZ Score | -10.46 |
| Piotroski Score | 2.00 |
| Working Capital | 437K |
| Total Assets | 11.62M |
| Ebit | -4.18M |
| Market Cap | 859.63K |
| Total Liabilities | 11.61M |
Poll Results
About Epigenomics AG (OTC:EPGNF) Stock
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. It offers Epi proColon, a blood-based test for the early detection of colorectal cancer; Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer, Epi BiSKit, a kit for the preparation of purified, bisulfite-converted DNA and, HCCBloodTest, a blood test for cirrhotic patients at high-risk for the development of hepatocellular carcinoma. The company was founded by Oliver Schacht, Christian Piepenbrock, Kurt Berlin, Jörn Walter, and Ivo G. Gut in 1998 and is headquartered in Berlin, Germany. ...
Frequently Asked Questions
-
What is the current Epigenomics AG (EPGNF) stock price?
-
Epigenomics AG(OTC:EPGNF) stock price is $1.12 in the last trading session. During the trading session, EPGNF stock reached the peak price of $1.12 while $0.79 was the lowest point it dropped to. The percentage change in EPGNF stock occurred in the recent session was 0.0% while the dollar amount for the price change in EPGNF stock was $0.
-
EPGNF's industry and sector of operation?
-
The OTC listed EPGNF is part of Medical - Specialties industry that operates in the broader Healthcare sector.
-
Who are the executives of EPGNF?
-
Frederic Hilke | Investor Relations Officer
Noel Thomas Doheny | Chief Executive Officer of Epigenomics Inc.
Andreas Danner | Executive Board Member
Hansjorg Plaggemars | Member of Executive Board
| -
How many employees does EPGNF have?
-
Number of EPGNF employees currently stands at 3. EPGNF operates from ZiegelhAeuser Landstrasse 3, Heidelberg, BE 69120, DE.
-
Link for EPGNF official website?
-
Official Website of EPGNF is: https://www.epigenomics.com
-
How do I contact EPGNF?
-
EPGNF could be contacted at phone #49 30 243 450 and can also be accessed through its website. EPGNF operates from ZiegelhAeuser Landstrasse 3, Heidelberg, BE 69120, DE.
-
How many shares of EPGNF are traded daily?
-
The average number of EPGNF shares traded daily for last 3 months was 555.89.
-
What is the market cap of EPGNF currently?
-
The market value of EPGNF currently stands at $1M with its latest stock price at $1.12